Presentazione standard di PowerPoint
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT - ScienceDirect
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia - Clinical Lymphoma, Myeloma and Leukemia
Expanded Comorbidity Definitions Improve Application of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for Children and Young Adults with Non-Malignant Diseases Receiving Allogeneic Hematopoietic Cell Transplantation - ScienceDirect
Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma - ScienceDirect
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older | Bone Marrow Transplantation
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect
Presentazione standard di PowerPoint
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. - Abstract - Europe PMC
Table 4 from Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. | Semantic Scholar
Presentazione standard di PowerPoint
Parameters of the HCT-CI 6 and their distribution (387 patients | Download Table
HCT-CI Score Impact on Morbidity and Mortality after Autologous Hema-... | Download Scientific Diagram
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients | Haematologica
Combining the Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Provides a Comprehensive Prognostic Model for CD34-Selected Allogeneic HCT - Biology of Blood and Marrow Transplantation
Recipient Selection for Hematopoietic Cell Transplantation (Section 1) - Hematopoietic Cell Transplants
Combining the Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Provides a Comprehensive Prognostic Model for CD34-Selected Allogeneic HCT - Biology of Blood and Marrow Transplantation
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. - Abstract - Europe PMC
Recipient Selection for Hematopoietic Cell Transplantation (Section 1) - Hematopoietic Cell Transplants
Frontiers | Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation
Recipient Selection for Hematopoietic Cell Transplantation (Section 1) - Hematopoietic Cell Transplants
